Development of immunoprecipitation - two-dimensional liquid chromatography - mass spectrometry methodology as biomarker read-out to quantify phosphorylated tau in cerebrospinal fluid from Alzheimer disease patients.

Journal of Chromatography. a
Sebastiaan BijttebierMarc Mercken

Abstract

In Alzheimer's disease (AD) brain, one of the histopathological hallmarks is the neurofibrillary tangles consisting of aggregated and hyperphosphorylated tau. Currently many tau binding antibodies are under development to target the extracellular species responsible for the spreading of the disease in the brain. As such, an in-house developed antibody JNJ-63733657 with picomolar affinity towards tau phosphorylated at both T212 and T217 (further named p217+tau) was recently tested in phase I clinical trial NCT03375697. Following multiple dose administration in healthy subjects and subjects with AD, there were dose dependant reductions in free p217+tau fragments in cerebrospinal fluid (CSF) following antibody administration, as measured with a novel single molecule ELISA assay (Simoa PT3 x PT82 assay), demonstrating epitope engagement of the therapeutic antibody [Galpern, Haeverans, Janssens, Triana-Baltzer, Kolb, Li, Nandy, Mercken, Van Kolen, Sun, Van Nueten, 2020]. Total p217+tau levels also were reduced in CSF as measured with the Simoa PT3 x PT82 assay. In this study we developed an orthogonal immunoprecipitation - liquid chromatography - triple quadrupole mass spectrometry (IP-LC-TQMS) assay to verify the observed reduction...Continue Reading

References

Jan 1, 1991·Acta Neuropathologica·H Braak, E Braak
Feb 24, 2001·Annals of the New York Academy of Sciences·P H St George-Hyslop
Dec 28, 2005·Journal of Chromatography. a·R TuyttenE L Esmans
Jun 9, 2009·Nature Cell Biology·Florence ClavagueraMarkus Tolnay
Apr 26, 2011·Acta Neuropathologica·Heiko Braak, Kelly Del Tredici
Oct 18, 2011·Amino Acids·Jan Fíla, David Honys
Jan 29, 2013·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·D H VuD R A Uges
May 22, 2013·Proceedings of the National Academy of Sciences of the United States of America·Florence ClavagueraMarkus Tolnay
Sep 15, 2014·Current Neurology and Neuroscience Reports·Michel GoedertMarkus Tolnay
Jul 15, 2015·Analytical Chemistry·Tereza ŠlechtováEva Tesařová
Jul 1, 2016·Neurology·Hanna ChoMyung Sik Lee
Mar 24, 2018·Neuron·Chihiro SatoRandall J Bateman
Oct 18, 2019·Frontiers in Aging Neuroscience·Nataliya I TrushinaRoland Brandt
Mar 13, 2020·Nature Medicine·Nicolas R BarthélemyUNKNOWN Dominantly Inherited Alzheimer Network
Apr 5, 2020·Nature Communications·Shorena JanelidzeOskar Hansson
Aug 25, 2020·Journal of Alzheimer's Disease : JAD·Gallen Triana-BaltzerHartmuth Kolb
Sep 8, 2020·Journal of Alzheimer's Disease : JAD·Kristof Van KolenMarc H Mercken

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.